These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16905977)

  • 1. Current status and future directions of molecular markers in renal cell carcinoma.
    Rini BI
    Curr Opin Urol; 2006 Sep; 16(5):332-6. PubMed ID: 16905977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and prognostic molecular markers in renal cell carcinoma.
    Tunuguntla HS; Jorda M
    J Urol; 2008 Jun; 179(6):2096-102. PubMed ID: 18423738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapy.
    Stillebroer AB; Mulders PF; Boerman OC; Oyen WJ; Oosterwijk E
    Eur Urol; 2010 Jul; 58(1):75-83. PubMed ID: 20359812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers in renal cell carcinoma.
    McGuire BB; Fitzpatrick JM
    Curr Opin Urol; 2009 Sep; 19(5):441-6. PubMed ID: 19584732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential histologic and molecular predictors of response to temsirolimus in patients with advanced renal cell carcinoma.
    Cho D; Signoretti S; Dabora S; Regan M; Seeley A; Mariotti M; Youmans A; Polivy A; Mandato L; McDermott D; Stanbridge E; Atkins M
    Clin Genitourin Cancer; 2007 Sep; 5(6):379-85. PubMed ID: 17956710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic and predictive biomarkers in renal cell carcinoma.
    Vickers MM; Heng DY
    Target Oncol; 2010 Jun; 5(2):85-94. PubMed ID: 20582732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic factors in renal cell carcinoma].
    Wen JJ; Zhou XJ
    Zhonghua Bing Li Xue Za Zhi; 2013 Dec; 42(12):850-3. PubMed ID: 24507112
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of the co-expression of carbonic anhydrase IX and vascular endothelial growth factor in patients with clear cell renal cell carcinoma.
    Phuoc NB; Ehara H; Gotoh T; Nakano M; Kamei S; Deguchi T; Hirose Y
    Oncol Rep; 2008 Sep; 20(3):525-30. PubMed ID: 18695901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting outcome to VEGF-targeted therapy in metastatic clear-cell renal cell carcinoma: data from recent studies.
    Golshayan AR; Brick AJ; Choueiri TK
    Future Oncol; 2008 Feb; 4(1):85-92. PubMed ID: 18241003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbonic anhydrase 9 in clear cell renal cell carcinoma: a marker for diagnosis, prognosis and treatment.
    Tostain J; Li G; Gentil-Perret A; Gigante M
    Eur J Cancer; 2010 Dec; 46(18):3141-8. PubMed ID: 20709527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathobiology, prognosis, and targeted therapy for renal cell carcinoma: exploiting the hypoxia-induced pathway.
    Pantuck AJ; Zeng G; Belldegrun AS; Figlin RA
    Clin Cancer Res; 2003 Oct; 9(13):4641-52. PubMed ID: 14581333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of carbonic anhydrase IX, α-methylacyl coenzyme a racemase, cytokeratin 7, and galectin-3 in the evaluation of renal neoplasms: a tissue microarray immunohistochemical study.
    Bing Z; Lal P; Lu S; Ziober A; Tomaszewski JE
    Ann Diagn Pathol; 2013 Feb; 17(1):58-62. PubMed ID: 22898056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analyses of potential predictive markers and survival data for a response to sunitinib in patients with metastatic renal cell carcinoma.
    Dornbusch J; Zacharis A; Meinhardt M; Erdmann K; Wolff I; Froehner M; Wirth MP; Zastrow S; Fuessel S
    PLoS One; 2013; 8(9):e76386. PubMed ID: 24086736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synchronous Metastatic Clear-Cell Renal Cell Carcinoma: A Distinct Morphologic, Immunohistochemical, and Molecular Phenotype.
    Kammerer-Jacquet SF; Brunot A; Pladys A; Bouzille G; Dagher J; Medane S; Peyronnet B; Mathieu R; Verhoest G; Bensalah K; Edeline J; Laguerre B; Lespagnol A; Mosser J; Dugay F; Belaud-Rotureau MA; Rioux-Leclercq N
    Clin Genitourin Cancer; 2017 Feb; 15(1):e1-e7. PubMed ID: 27444986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney cancer: Carbonic anhydrase IX in resected clear cell RCC.
    Pickering LM; Larkin J
    Nat Rev Urol; 2015 Jun; 12(6):309-10. PubMed ID: 26032554
    [No Abstract]   [Full Text] [Related]  

  • 17. Factors associated with outcome in patients with advanced renal cell carcinoma in the era of antiangiogenic agents.
    Choueiri TK
    Clin Genitourin Cancer; 2008 Mar; 6(1):15-20. PubMed ID: 18501077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular markers of prognosis in renal cell carcinoma: Insight into tumor biology helps define risk and provides targets for therapy.
    Wood CG
    J Surg Oncol; 2006 Sep; 94(4):264-5. PubMed ID: 16941531
    [No Abstract]   [Full Text] [Related]  

  • 19. Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy.
    Bui MH; Seligson D; Han KR; Pantuck AJ; Dorey FJ; Huang Y; Horvath S; Leibovich BC; Chopra S; Liao SY; Stanbridge E; Lerman MI; Palotie A; Figlin RA; Belldegrun AS
    Clin Cancer Res; 2003 Feb; 9(2):802-11. PubMed ID: 12576453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue-based molecular markers for renal cell carcinoma.
    Rink M; Chun FK; Robinson B; Sun M; Karakiewicz PI; Bensalah K; Fisch M; Scherr DS; Lee RK; Margulis V; Shariat SF
    Minerva Urol Nefrol; 2011 Dec; 63(4):293-308. PubMed ID: 21996985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.